Stifel Initiates Coverage of Immunome with Hold Rating

Stifel initiated coverage of Immunome (NASDAQCM: IMNM) with a Hold rating on October 1, 2026. The stock closed at $20.89 on the rating date, versus $21.51 on September 30, a decline of $0.62 or 2.9%. The neutral initiation is unlikely to be a major catalyst absent a price target or further investment thesis details.